Abbott Laboratories (USD)
ABT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range92.32 | 93.80
52-Wk Range- | -
Last Close93.04
Mkt Cap (m)164,573.37
Dividend yield1.46
ISINUS0028241000
Volume2,923,198.00
Exchange VenueNYS

Company Profile

Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.

Key Information
Price/Earning46.99
Price/Book5.45
Price/Sales5.17
P/CF27.01
Rev Growth (3 year avg)15.23
EPS Growth (3 year avg)0.30
Operating Margin % 14.21
Net Margin %11.56
Return on Equity11.97
Debt/Equity0.61

Documents

Prospectus
en 23/06/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.abbott.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)20,247.0020,405.0020,853.0027,390.0030,578.0031,904.00
Operating Income (m)2,599.002,867.003,185.001,726.003,650.004,532.00
Net Income (m)2,284.004,423.001,400.00477.002,368.003,687.00
Basic EPS1.502.940.940.271.342.07
Avg. Diluted Shares Outstanding (m)1,527.001,506.001,483.001,749.001,770.001,781.00
Balance Sheet
USD201420152016201720182019
Current Assets (m)15,261.0014,155.0026,776.0020,147.0014,632.0015,667.00
Non Current Assets (m)26,014.0027,092.0025,890.0056,103.0052,541.0052,220.00
Total Assets (m)41,275.0041,247.0052,666.0076,250.0067,173.0067,887.00
Current Liabilities (m)10,532.009,186.006,660.008,912.009,012.0010,863.00
Total Liabilities (m)------
Total Equity (m)21,526.0021,211.0020,538.0030,897.0030,524.0031,088.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)3,675.002,966.003,203.005,570.006,300.006,136.00
Capital Expenditure (m)-1,077.00-1,110.00-1,121.00-1,135.00-1,394.00-1,638.00
Figures are quoted in USD unless stated otherwise
-
No change
$
93.04
Last Price